98%
921
2 minutes
20
Background: In recent years, the popularity of multi-arm multi-stage, seamless adaptive, and platform trials has increased. However, many design-related questions and questions regarding which operating characteristics should be evaluated to determine the potential performance of a specific trial design remain and are often further complicated by the complexity of such trial designs.
Methods: A systematic search was conducted to review existing software for the design of platform trials, whereby multi-arm multi-stage trials were also included. The results of this search are reported both on the literature level and the software level, highlighting the software judged to be particularly useful.
Results: In recent years, many highly specialized software packages targeting single design elements on platform studies have been released. Only a few of the developed software packages provide extensive design flexibility, at the cost of limited access due to being commercial or not being usable as out-of-the-box solutions.
Conclusions: We believe that both an open-source modular software similar to OCTOPUS and a collaborative effort will be necessary to create software that takes advantage of and investigates the impact of all the flexibility that platform trials potentially provide.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931508 | PMC |
http://dx.doi.org/10.1186/s13063-021-05130-x | DOI Listing |
BMJ Open
August 2025
Faculty of Medicine and Health, Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
Introduction: As chronic low back pain (LBP) remains one of the most pressing global health challenges, digital health emerges as an opportunity to deliver evidence-based care at scale. In this context, the My Back Exercise app has been developed to support people with LBP in self-managing their condition. This study aims to determine the effectiveness of the My Back Exercise app to improve physical function in people with chronic non-specific LBP.
View Article and Find Full Text PDFLancet Oncol
August 2025
Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie Hospital NHS Foundation Trust, Manchester, UK; Department of Urology, Salford Royal Hospital, Manchester, UK.
Perioper Med (Lond)
July 2025
Critical Care and Perioperative Medicine Research Group, William Harvey Research Institute, Queen Mary University of London, London, UK.
The traditional model for testing new treatments, before widespread usage in clinical practice, is the parallel group randomised trial. However, these are often inefficient, time-consuming and expensive, which can be barriers to the timely improvement of clinical care. This is a particular issue for anaesthesia and perioperative medicine where funding for large clinical trials is often scarce.
View Article and Find Full Text PDFBiometrics
April 2025
MRC Biostatistics Unit, University of Cambridge, Cambridge, CB2 0RS, United Kingdom.
Platform trials are an efficient way of testing multiple treatments. We consider platform trials where, if a treatment is found to be superior to the control, it will become the new standard of care. The remaining treatments are then tested against this new control.
View Article and Find Full Text PDFNIHR Open Res
April 2025
Imperial College London Department of Surgery and Cancer, London, England, UK.
Background: Venous leg ulceration (VLU) is the most severe form of venous disease and an important burden to patients and society. Many treatments for VLU exist, including wound therapies, medications, and surgical interventions. However, high-level randomized trial data supporting leg ulcer treatments are lacking, limiting their adoption in clinical practice.
View Article and Find Full Text PDF